Monte Rosa Therapeutics, Inc. GLUE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $159.86M+104% | $129.88M-42.1% | $208.34M+65.9% | $69.43M-36.2% | $78.53M-21.3% | ||
| $677.55M+104% | $393.19M+4.2% | $401.82M+60.0% | $299.47M+7.8% | $332.28M+66.9% | ||
| $28.41M-3.2% | $25.99M-11.9% | $27.6M-12.2% | $29.05M-12.6% | $29.34M-13.8% | ||
| $736.43M+87.3% | $448.66M+2.3% | $459.84M+45.9% | $359.59M+4.5% | $393.2M+47.4% | ||
| $7.9M+21.7% | $3.55M-79.4% | $14.51M+265% | $5.58M-13.8% | $6.49M-5.0% | ||
| $103.64M+515% | $111.33M+589% | $111.89M+346% | $8.06M— | $16.86M— | ||
| $71.04M+20.0% | $64.21M-59.1% | $61.44M+47.6% | $41.85M-1.2% | $59.22M+43.4% | ||
| $214.51M+81.7% | $215.6M-0.1% | $214M+95.2% | $91.51M-23.4% | $118.04M+3.3% | ||
| $8K+33.3% | $7K+16.7% | $6K0.0% | $6K0.0% | $6K+20.0% | ||
| -$521.72M-33.2% | -$477.21M-8.8% | -$431.08M+4.6% | -$404M+5.6% | -$391.7M+1.5% | ||
| $521.92M+89.7% | $233.06M+4.5% | $245.84M+19.7% | $268.08M+19.3% | $275.16M+80.4% | ||
| $736.43M+87.3% | $448.66M+2.3% | $459.84M+45.9% | $359.59M+4.5% | $393.2M+47.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Monte Rosa Therapeutics, Inc.'s total assets?
- Monte Rosa Therapeutics, Inc. (GLUE) holds $736.4M in total assets, up 87.3% year over year.
- How much debt does Monte Rosa Therapeutics, Inc. have?
- Monte Rosa Therapeutics, Inc. carries $39.1M in total debt against $521.9M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Monte Rosa Therapeutics, Inc. have?
- Monte Rosa Therapeutics, Inc. holds $159.9M in cash and equivalents.
- Can Monte Rosa Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 9.54 — current assets exceed current liabilities.
- Where does Monte Rosa Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Monte Rosa Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
